Litigation Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
✉ Email this page to a colleague
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-05-12 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | Both | Referred To | |
| Patents | 10,213,400; 6,045,501; 6,228,398; 6,309,663; 6,315,720; 6,419,960; 6,514,531; 6,755,784; 7,268,156; 7,668,730; 7,765,106; 7,765,107; 7,772,209; 7,895,059; 8,101,209; 8,263,650; 8,324,275; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 9,050,302; 9,486,426 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Biologic Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-05-12 | 1 | Complaint | United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 … for patent infringement and for a declaratory judgement of patent infringement under the patent laws…PageID #: 2 (the “’956 patent”), and 10,966,931 (the “’931 patent”) owned by Jazz Pharmaceuticals (…’963 patent entitled, “Sensitive Drug Distribution System and Method.” A copy of the ’963 patent is attached…of the ’931 patent is attached hereto as Exhibit E. 27. The claims of the patents-in-suit cover | External link to document |
| 2021-06-03 | 11 | Answer to Complaint | United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 (…United States Patent Nos. 8,731,963 (the “’963 patent”), 10,758,488 (the “’488 patent”), 10,813,885 (… for patent infringement and for a declaratory judgement of patent infringement under the patent laws … (the “’885 patent”), 10,959,956 (the “’956 patent”), and 10,966,931 (the “’931 patent”) owned by Jazz… for patent infringement and for a declaratory judgment of patent infringement under the patent laws | External link to document |
| 2022-06-23 | 117 | Motion for Judgment on the Pleadings | counterclaim seeking delisting of U.S. Patent No. 8,731,963 (the “’963 patent”) from the Orange Book (see D.I…submit a request to the FDA to delist the ’963 patent pursuant to 21 U.S.C. § 355(c)(3)(D)(ii)(I). The… 12 May 2021 1:21-cv-00691 830 Patent None District Court, D. Delaware | External link to document |
| 2022-06-23 | 118 | Opening Brief in Support | seeking delisting of Jazz’s U.S. Patent No. 8,731,963 (the “’963 patent”) from the FDA’s Orange Book.1 …the FDA “the patent number and expiration date of each patent for which a claim of patent infringement…Orange Book-listed patents for XYREM. D.I. 1, Exhibit F at 163. Of the seven patents Jazz has accused …only the ’963 patent is listed in the Orange Book and therefore is the only asserted patent that could …26, and 27 of the ’963 Patent, along with all claims of six other issued patents in the family. Only claims | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
